How Much Revenue Could Pfizer’s Oral COVID-19 Pill Fetch?
Pfizer, Inc. (NYSE: PFE) announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for use by the U.S.
COVID-19 Takes Another Bite Out Of Agnico Eagle Earnings
Despite stringent protocols, there has been an increase in COVID-19 cases at Agnico Eagle Mines Ltd’s (NYSE: AEM) Nunavut operations and the company is taking steps to gradually reduce the workforce and activity levels, according to BofA Securities.
Analysts Bump Up Cintas Price Target Post Q2 Results
Several analysts raised the price target&nbs
Read Why Daiwa Reduced Alibaba Price Target By 13%
Daiwa analyst John Choi lowered the price target on Alibaba Group Holding Ltd (NYSE:BABA) to $170 from $195 and reiterated a Buy. The…
China Regulators Suspend Alibaba Cloud Partnership; CLSA Remains Bullish On Alibaba
Chinese regulators suspended an information-sharing partnership with Alibaba Group Holding Ltd (NYSE: BABA) Alibaba Cloud Computing,
Read Why Loop Capital Slashed Twitter Price Target By 22%
Loop Capital analyst Alan Gould lowered the price target on Twitter Inc (NYSE:TWTR) to $65 from $84, implying 46.5% upside, and reiterated a…
Read How Analysts Reacted To Micron Post Q1 Earnings
Analysts hailed Micron Technology Inc's (NASDAQ: MU) Q1 results and Q2 outlook by lifting their price targets</
Read How Analysts View Oracle Post Cerner Deal
Keybanc analyst Michael Turits downgraded Oracle Corp (NYSE:ORCL) from Overweight to Sector Weight. Patrick Walravens from JMP Securities maintained a Hold on Oracle. Stifel analyst Brad…
Read Why Citi Is Bullish On Marvell
Citi analyst Atif Malik raised the price target on Marvell Technology Inc (NASDAQ:MRVL) from $87 to $97 and reiterated a Buy. The price…
Read Why Loop Capital Slashed Meta Price Target By 9.5%; Remains Bullish
Loop Capital analyst Alan Gould cut the price target on Meta Platforms Inc (NASDAQ:FB) to $380 from $420 and reiterated a Buy. The…